{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:20:23Z","timestamp":1772634023897,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beha.2025.101597","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:57:46Z","timestamp":1738828666000},"page":"101597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A reflection on Arnold Caplan, the father of MSC"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-4044","authenticated-orcid":false,"given":"James M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beha.2025.101597_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.beha.2025.101597_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"issue":"13","key":"10.1016\/j.beha.2025.101597_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/15353702231194250","article-title":"The US Food and Drug Administration the mechanisms of action and other considerations for cell-based therapy candidates","volume":"248","author":"Caplan","year":"2023","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.beha.2025.101597_bib4","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells)[MPCs]: implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2025.101597_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2025.101597_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in patients with hematologic malignancy","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2025.101597_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1352458517703802","article-title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","volume":"24","author":"Cohen","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.beha.2025.101597_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbmt.2014.12.025","article-title":"Single & multiple dose MultiStem (Multipotent Adult Progenitor Cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial","volume":"21","author":"Maziarz","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2025.101597_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/acr2.11356","article-title":"Optimization of human mesenchymal stem cells for rheumatoid arthritis: implications for improved therapeutic outcomes","volume":"4","author":"Bonfield","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.beha.2025.101597_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2022.12.001","article-title":"A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis","volume":"22","author":"Roesch","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.beha.2025.101597_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100742","article-title":"Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?","volume":"46","author":"Hamdan","year":"2021","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.beha.2025.101597_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","article-title":"Mesenchymal stem cell therapy: two steps forward, one step back","volume":"16","author":"Ankrum","year":"2010","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1016\/j.beha.2025.101597_bib13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/sctm.20-0521","article-title":"Donor -defined mesenchymal stem cell antimicrobial potency against non-tuberculous mycobacterium","volume":"10","author":"Bonfield","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.beha.2025.101597_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2022.103913","article-title":"Human bone-marrow-derived mesenchymal stem cells rescue neonatal CPAP-induced airway hyperreactivity","volume":"302","author":"MacFarlane","year":"2022","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.beha.2025.101597_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.573065","article-title":"Enhancing CF immune regulation","volume":"12","author":"Van Heeckeren","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.beha.2025.101597_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0961203320968897","article-title":"Intrarenal injection of mesenchymal stem cells for treatment of lupus nephritis in mice-a pilot study","volume":"30","author":"Bukulmez","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.beha.2025.101597_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med"},{"issue":"4","key":"10.1016\/j.beha.2025.101597_bib18","first-page":"307","article-title":"Mesenchymal stem cells and COVID-19: the process of discovery and translation","volume":"2","author":"Caplan","year":"2021","journal-title":"Biomater Transl"},{"issue":"1","key":"10.1016\/j.beha.2025.101597_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41536-024-00347-1","article-title":"hMSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophage programming via effereocytosis","volume":"9","author":"Dave","year":"2024","journal-title":"NPJ Regen Med"},{"issue":"2","key":"10.1016\/j.beha.2025.101597_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.29709","article-title":"Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche","volume":"138","author":"Correa","year":"2016","journal-title":"Int J Cancer"},{"issue":"3\u20134","key":"10.1016\/j.beha.2025.101597_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/ten.tea.2016.0559","article-title":"Transcriptome-wide analyses of human neonatal articular cartilage and human mesenchymal stem cell-derived cartilage provide a new molecular target for evaluating engineered cartilage","volume":"24","author":"Somoza","year":"2018","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.beha.2025.101597_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/stcltm\/szac026","article-title":"An interview with a cell therapy pioneer, Arnold caplan","volume":"11","author":"Atala","year":"2022","journal-title":"Stem Cells Translational Medicine"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692625000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692625000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:22:32Z","timestamp":1741609352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692625000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521692625000027"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2025.101597","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A reflection on Arnold Caplan, the father of MSC","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2025.101597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101597"}}